KIMBERLY CLARK CORP

KMB Nasdaq CIK: 0000055785

Company Information

Industry Converted Paper & Paperboard Prods (No Contaners/Boxes)
SIC Code 2670
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 351 PHELPS DRIVE, IRVING, TX, 75038
Mailing Address P O BOX 619100, DALLAS, TX, 75261-9100
Phone 9722811200
Fiscal Year End 1231
EIN 390394230

Financial Overview

FY2025

$1.01B
Cash & Equivalents
$5.22
EPS

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report February 12, 2026 View on SEC
4 Insider stock transaction report February 9, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 5, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
8-K Current report of material events January 29, 2026 View on SEC
8-K Current report of material events January 27, 2026 View on SEC
8-K Current report of material events January 16, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC

Annual Reports

10-K February 12, 2026
  • Achieved 5% organic sales growth in 2024, demonstrating strong pricing power and brand strength despite volume pressures.
  • Launched the 'K-C Strategic Transformation Initiative' targeting $300-500 million in annual savings by 2026 to enhance profitability and efficiency.
View Analysis

Material Events

8-K Acquisition January 29, 2026
High Impact
  • Kimberly-Clark (K-C) is acquiring Kenvue Inc. in an all-stock merger valued at approximately $40 billion.
  • The acquisition significantly expands K-C's presence into the consumer health sector with iconic brands like Tylenol, Listerine, and Band-Aid.
View Analysis

Insider Trading

BUY 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2670)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.